Efficacy of Etanercept in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Etanercept Humans Immunoglobulins, Intravenous Retrospective Studies Stevens-Johnson Syndrome / drug therapy

Journal

Cutis

ISSN: 2326-6929

Titre abrégé: Cutis

Pays: United States

ID NLM: 0006440

Informations de publication

Date de publication:
Jun 2021

Historique:

entrez: 27 7 2021

pubmed: 28 7 2021

medline: 25 9 2021

Statut: ppublish

Résumé

It has been suggested that the use of etanercept for treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) might provide improved mortality benefit and decreased skin healing times. This retrospective study compared the use of single-dose subcutaneous etanercept to intravenous immunoglobulin (IVIG) and supportive care alone. Thirteen patients were treated with a single dose (50 mg) of subcutaneous etanercept. Results of this study support the use of etanercept as a potentially beneficial agent in the treatment of SJS/TEN.

Identifiants

DOI: 10.12788/cutis.0288 PMID: 34314327

pubmed: 34314327

pii: cutis.0288

doi: 10.12788/cutis.0288

doi:

Substances chimiques

Immunoglobulins, Intravenous 0

Etanercept OP401G7OJC

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E22-E28

Auteurs

Sean David Dreyer (SD)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Juan Torres (J)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Marie Stoddard (M)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Erica Leavitt (E)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Adam Sutton (A)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Maria Aleshin (M)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Ashley Crew (A)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Scott Worswick (S)

Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebraska, Lincoln. Dr. Aleshin is from the Department of Dermatology, Stanford University, California. Drs. Crew and Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen

1.00

Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.

1.00

Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.

1.00

Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.

1.00

Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs aux cytokines › Récepteurs aux facteurs de nécrose tumorale › Étanercept › Efficacy of Etanercept in the Treatment of...

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Efficacy of Etanercept in the Treatment of...

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Immunoglobulines par voie veineuse › Efficacy of Etanercept in the Treatment of...

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Efficacy of Etanercept in the Treatment of...

questionsmedicales.fr › Troubles dus à des produits chimiques › Effets secondaires indésirables des médicaments › Hypersensibilité médicamenteuse › Toxidermies › Syndrome de Stevens-Johnson › Efficacy of Etanercept in the Treatment of...